As Ignyta INC (RXDX) Stock Price Declined, Cormorant Asset Management LLC Upped Its Stake

March 14, 2018 - By Marie Mckinney

Investors sentiment decreased to 2.28 in 2017 Q3. Its down 0.68, from 2.96 in 2017Q2. It is negative, as 14 investors sold RXDX shares while 18 reduced holdings. 35 funds opened positions while 38 raised stakes. 44.98 million shares or 5.65% more from 42.58 million shares in 2017Q2 were reported. Wells Fargo And Mn invested in 0% or 988,227 shares. Spark Mngmt Lc accumulated 57,000 shares. Ghost Tree Cap Limited Liability Com accumulated 550,000 shares or 1.44% of the stock. Tiaa Cref Management Lc has 415,586 shares for 0% of their portfolio. 67,700 were accumulated by Knott David M. Tudor Invest Corporation Et Al has 0% invested in Ignyta, Inc. (NASDAQ:RXDX) for 11,482 shares. Connor Clark Lunn Invest Mngmt Ltd reported 0% of its portfolio in Ignyta, Inc. (NASDAQ:RXDX). 353,125 are owned by Morgan Stanley. Citadel Advsr Ltd Company accumulated 78,242 shares or 0% of the stock. Deutsche National Bank Ag invested 0% in Ignyta, Inc. (NASDAQ:RXDX). Cutter Company Brokerage accumulated 11,800 shares. Moreover, Parallax Volatility Advisers Limited Partnership has 0% invested in Ignyta, Inc. (NASDAQ:RXDX) for 3,910 shares. Manufacturers Life Company The reported 0% stake. Nationwide Fund Advisors, Pennsylvania-based fund reported 140,818 shares. Tang Cap Mgmt Llc has 17.96% invested in Ignyta, Inc. (NASDAQ:RXDX) for 4.76 million shares.

Cormorant Asset Management Llc increased its stake in Ignyta Inc (RXDX) by 133.33% based on its latest 2017Q3 regulatory filing with the SEC. Cormorant Asset Management Llc bought 2.00M shares as the company’s stock declined 28.13% while stock markets rallied. The hedge fund held 3.50 million shares of the health care company at the end of 2017Q3, valued at $43.23 million, up from 1.50M at the end of the previous reported quarter. Cormorant Asset Management Llc who had been investing in Ignyta Inc for a number of months, seems to be bullish on the $1.82B market cap company. It closed at $26.95 lastly. It is down 14.24% since March 14, 2017 and is uptrending. It has underperformed by 2.46% the S&P500.

Cormorant Asset Management Llc, which manages about $841.40 million and $566.36M US Long portfolio, decreased its stake in Portola Pharmaceuticals Inc (NASDAQ:PTLA) by 400,000 shares to 500,000 shares, valued at $27.02 million in 2017Q3, according to the filing. It also reduced its holding in Ardelyx Inc (NASDAQ:ARDX) by 850,000 shares in the quarter, leaving it with 572,738 shares, and cut its stake in Bluebird Bio Inc (NASDAQ:BLUE).

More news for Ignyta, Inc. (NASDAQ:RXDX) were recently published by:, which released: “Form POS AM Ignyta, Inc.” on February 12, 2018.‘s article titled: “Why Ignyta, Inc. Stock Is Soaring Today” and published on December 22, 2017 is yet another important article.

Ignyta, Inc. (NASDAQ:RXDX) Ratings Coverage

Among 10 analysts covering Ignyta (NASDAQ:RXDX), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Ignyta has $38 highest and $1500 lowest target. $24.13’s average target is -10.46% below currents $26.95 stock price. Ignyta had 20 analyst reports since August 12, 2015 according to SRatingsIntel. SunTrust initiated the shares of RXDX in report on Tuesday, November 21 with “Buy” rating. Piper Jaffray maintained it with “Overweight” rating and $34 target in Wednesday, August 12 report. The firm has “Outperform” rating by Credit Suisse given on Tuesday, March 15. JP Morgan initiated the shares of RXDX in report on Thursday, June 23 with “Overweight” rating. The stock of Ignyta, Inc. (NASDAQ:RXDX) has “Buy” rating given on Sunday, June 4 by Cantor Fitzgerald. Jefferies maintained the stock with “Buy” rating in Friday, October 20 report. Ladenburg Thalmann downgraded the shares of RXDX in report on Tuesday, December 26 to “Neutral” rating. The rating was downgraded by SunTrust on Tuesday, December 26 to “Hold”. The rating was initiated by Canaccord Genuity with “Buy” on Monday, October 26. Jefferies initiated Ignyta, Inc. (NASDAQ:RXDX) rating on Friday, October 23. Jefferies has “Buy” rating and $18 target.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.